Propanc Biopharma, Inc.

PPCB ·Healthcare, Drug Manufacturers - General, Australia
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
NT 10-K Sep 30, 2019
8-K Sep 9, 2019
RW Aug 21, 2019
RW WD Aug 20, 2019
RW Aug 19, 2019
8-K Aug 6, 2019
8-K Jul 10, 2019
8-K Jul 1, 2019
3 Jun 28, 2019
EFFECT Jun 21, 2019
8-K Jun 21, 2019
CORRESP Jun 20, 2019
S-1/A Jun 14, 2019
8-K May 30, 2019
UPLOAD May 29, 2019
S-1 May 23, 2019
4 May 22, 2019
4 May 17, 2019
10-Q May 15, 2019
8-K May 15, 2019
DEF 14C Mar 18, 2019
EFFECT Mar 7, 2019
PRE 14C Mar 7, 2019
424B3 Mar 7, 2019
CORRESP Mar 5, 2019
← Newer Page 10 of 18 · 435 filings Older →